供应链集中度对医药制造企业创新的影响——市场地位的调节作用  

The Impact of Supply Chain Concentration on Innovation in Pharmaceutical Manufacturing Firms:Moderating Role of Market Position

作　　者：钟雯 陈倬[1] Zhong Wen;Chen Zhuo(School of Management,Wuhan Polytechnic University,Wuhan 430023,China)

机构地区：[1]武汉轻工大学管理学院,湖北武汉430023

出　　处：《科技创业月刊》2024年第6期25-32,共8页Journal of Entrepreneurship in Science & Technology

基　　金：湖北省高等学校哲学社会科学研究重大项目(21ZD072)。

摘　　要：在经济全球化时代背景下,创新不仅是企业发展的必由之路,更是推动社会进步的重要力量。基于2015-2022年我国A股医药制造上市公司样本,使用多元线性回归模型,实证研究供应链集中度对企业创新的影响,同时将市场地位作为调节变量,深入探讨市场地位在其中的调节作用。研究发现:供应链上下游集中度与企业创新能力均呈负相关关系,即供应商和客户的集中度越高,企业创新能力越低;市场地位对供应链集中度与企业创新之间的关系产生显著的正向调节作用。研究结论为企业根据自身市场地位调节供应链集中度,进而促进其创新发展提供了参考。In an era of economic globalisation,innovation is not only a key route to business success,but also vital to societal growth.Based on a sample of A-share listed companies in China’s pharmaceutical manufacturing industry from 2015 to 2022,a multiple linear regression model was used to empirically investigate the impact of supply chain concentration on corporate innovation,while market position was added as a moderating variable to the model to deeply explore the moderating role of market position in it.The study shows that both upstream and downstream supply chain concentration and corporate innovation capability are negatively correlated,in other words,higher supplier and customer concentration leads to lower firms’ability to innovate,However,market position has a significant positive moderating effect on the relationship.The study’s findings contribute to the validation of the variables influencing firm innovation from the standpoint of supply chain concentration.They also offer a theoretical foundation and useful insights into how businesses can control supply chain concentration in accordance with their particular market position to foster innovation.

关 键 词：供应链集中度 医药制造企业 企业创新 

分 类 号：F272.3[经济管理—企业管理]